These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 33555101

  • 1. Predictors of Initial Hydroxychloroquine Receipt Among Medicaid Beneficiaries With Incident Systemic Lupus Erythematosus.
    Pryor KP, Xu C, Collins JE, Costenbader KH, Feldman CH.
    Arthritis Care Res (Hoboken); 2022 Aug; 74(8):1263-1268. PubMed ID: 33555101
    [Abstract] [Full Text] [Related]

  • 2. Area-Level Predictors of Medication Nonadherence Among US Medicaid Beneficiaries With Lupus: A Multilevel Study.
    Feldman CH, Costenbader KH, Solomon DH, Subramanian SV, Kawachi I.
    Arthritis Care Res (Hoboken); 2019 Jul; 71(7):903-913. PubMed ID: 30055088
    [Abstract] [Full Text] [Related]

  • 3. Dynamic patterns and predictors of hydroxychloroquine nonadherence among Medicaid beneficiaries with systemic lupus erythematosus.
    Feldman CH, Collins J, Zhang Z, Subramanian SV, Solomon DH, Kawachi I, Costenbader KH.
    Semin Arthritis Rheum; 2018 Oct; 48(2):205-213. PubMed ID: 29458974
    [Abstract] [Full Text] [Related]

  • 4. Medication Nonadherence Is Associated With Increased Subsequent Acute Care Utilization Among Medicaid Beneficiaries With Systemic Lupus Erythematosus.
    Feldman CH, Yazdany J, Guan H, Solomon DH, Costenbader KH.
    Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1712-21. PubMed ID: 26097166
    [Abstract] [Full Text] [Related]

  • 5. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
    Rainsford KD, Parke AL, Clifford-Rashotte M, Kean WF.
    Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
    [Abstract] [Full Text] [Related]

  • 6. Racial Differences in Contraception Encounters and Dispensing Among Female Medicaid Beneficiaries With Systemic Lupus Erythematosus.
    Williams JN, Xu C, Costenbader KH, Bermas BL, Pace LE, Feldman CH.
    Arthritis Care Res (Hoboken); 2021 Oct; 73(10):1396-1404. PubMed ID: 32526084
    [Abstract] [Full Text] [Related]

  • 7. Association between hydroxychloroquine levels and disease activity in a predominantly Hispanic systemic lupus erythematosus cohort.
    Geraldino-Pardilla L, Perel-Winkler A, Miceli J, Neville K, Danias G, Nguyen S, Dervieux T, Kapoor T, Giles J, Askanase A.
    Lupus; 2019 Jun; 28(7):862-867. PubMed ID: 31122136
    [Abstract] [Full Text] [Related]

  • 8. Baseline Retinal Examinations in Patients With Systemic Lupus Erythematosus Newly Initiating Hydroxychloroquine Treatment in a US Medicaid Systemic Lupus Erythematosus Population, 2000-2010.
    Lin TC, Marmor MF, Barbhaiya M, Guan H, Chen SK, Feldman CH, Costenbader KH.
    Arthritis Care Res (Hoboken); 2018 Nov; 70(11):1700-1706. PubMed ID: 29409142
    [Abstract] [Full Text] [Related]

  • 9. Hydroxychloroquine in patients with systemic lupus erythematosus with end-stage renal disease.
    Bethel M, Yang FM, Li S, Nahman NS, Oliver AM, Machua W, Carbone LD.
    J Investig Med; 2016 Apr; 64(4):908-10. PubMed ID: 26911274
    [Abstract] [Full Text] [Related]

  • 10. Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study.
    Chen YM, Lin CH, Lan TH, Chen HH, Chang SN, Chen YH, Wang JS, Hung WT, Lan JL, Chen DY.
    Rheumatology (Oxford); 2015 Jul; 54(7):1244-9. PubMed ID: 25587177
    [Abstract] [Full Text] [Related]

  • 11. Racial/Ethnic variation in all-cause mortality among United States medicaid recipients with systemic lupus erythematosus: a Hispanic and asian paradox.
    Gómez-Puerta JA, Barbhaiya M, Guan H, Feldman CH, Alarcón GS, Costenbader KH.
    Arthritis Rheumatol; 2015 Mar; 67(3):752-60. PubMed ID: 25590668
    [Abstract] [Full Text] [Related]

  • 12. Association of Hydroxychloroquine Use With Decreased Incident Atrial Fibrillation in Systemic Lupus Erythematosus.
    Gupta A, Shields KJ, Manzi S, Wasko MC, Sharma TS.
    Arthritis Care Res (Hoboken); 2021 Jun; 73(6):828-832. PubMed ID: 33098269
    [Abstract] [Full Text] [Related]

  • 13. Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis.
    Feldman CH, Hiraki LT, Winkelmayer WC, Marty FM, Franklin JM, Kim SC, Costenbader KH.
    Arthritis Rheumatol; 2015 Jun; 67(6):1577-85. PubMed ID: 25772621
    [Abstract] [Full Text] [Related]

  • 14. Clinical Significance of Monitoring Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis.
    Garg S, Unnithan R, Hansen KE, Costedoat-Chalumeau N, Bartels CM.
    Arthritis Care Res (Hoboken); 2021 May; 73(5):707-716. PubMed ID: 32004406
    [Abstract] [Full Text] [Related]

  • 15. Continuation Rate, Safety and Efficacy of Hydroxychloroquine Treatment in a Retrospective Cohort of Systemic Lupus Erythematosus in a Japanese Municipal Hospital.
    Hosokawa Y, Oiwa H.
    Intern Med; 2020 Oct 15; 59(20):2485-2490. PubMed ID: 32641656
    [Abstract] [Full Text] [Related]

  • 16. Compliance and persistence with hydroxychloroquine in South Korean patients with systemic lupus erythematosus.
    Lee SG, Park EK, Park JH, Kweon SM, Kim YK, Kim GT.
    Lupus; 2018 Apr 15; 27(5):753-761. PubMed ID: 29157178
    [Abstract] [Full Text] [Related]

  • 17. Understanding Nonadherence with Hydroxychloroquine Therapy in Systemic Lupus Erythematosus.
    Liu LH, Fevrier HB, Goldfien R, Hemmerling A, Herrinton LJ.
    J Rheumatol; 2019 Oct 15; 46(10):1309-1315. PubMed ID: 30709949
    [Abstract] [Full Text] [Related]

  • 18. Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus.
    Fasano S, Pierro L, Pantano I, Iudici M, Valentini G.
    J Rheumatol; 2017 Jul 15; 44(7):1032-1038. PubMed ID: 28507183
    [Abstract] [Full Text] [Related]

  • 19. Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease.
    Iudici M, Pantano I, Fasano S, Pierro L, Charlier B, Pingeon M, Dal Piaz F, Filippelli A, Izzo V.
    Lupus; 2018 Feb 15; 27(2):265-272. PubMed ID: 28659047
    [Abstract] [Full Text] [Related]

  • 20. Hydroxychloroquine and Mortality Among Patients With Systemic Lupus Erythematosus in the General Population.
    Jorge A, McCormick N, Lu N, Zheng Y, Esdaile J, De Vera M, Choi H, Aviña-Zubieta JA.
    Arthritis Care Res (Hoboken); 2021 Aug 15; 73(8):1219-1223. PubMed ID: 32407570
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.